IRIS
GAETA, Giovanni Battista
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.597
EU - Europa 5.224
AS - Asia 1.049
SA - Sud America 19
Continente sconosciuto - Info sul continente non disponibili 17
AF - Africa 12
OC - Oceania 5
Totale 11.923
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.570
IE - Irlanda 1.786
UA - Ucraina 956
GB - Regno Unito 760
DE - Germania 480
CN - Cina 472
SG - Singapore 351
IT - Italia 304
SE - Svezia 289
FI - Finlandia 229
GR - Grecia 175
TR - Turchia 130
FR - Francia 123
BE - Belgio 34
CZ - Repubblica Ceca 30
CA - Canada 19
IR - Iran 18
IN - India 17
KR - Corea 17
EU - Europa 15
HK - Hong Kong 12
PL - Polonia 12
NL - Olanda 11
BR - Brasile 8
RU - Federazione Russa 7
TH - Thailandia 7
TW - Taiwan 7
CH - Svizzera 6
MX - Messico 6
ET - Etiopia 5
BO - Bolivia 4
ID - Indonesia 4
RO - Romania 4
AU - Australia 3
PE - Perù 3
VN - Vietnam 3
AL - Albania 2
AP - ???statistics.table.value.countryCode.AP??? 2
AR - Argentina 2
AT - Austria 2
BF - Burkina Faso 2
CO - Colombia 2
EG - Egitto 2
ES - Italia 2
HU - Ungheria 2
IQ - Iraq 2
JP - Giappone 2
LT - Lituania 2
LV - Lettonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SC - Seychelles 2
AM - Armenia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CY - Cipro 1
GL - Groenlandia 1
IL - Israele 1
JM - Giamaica 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 11.923
Salva come PNG Salva come JPEG
Città #
Dublin 1.780
Jacksonville 1.401
Chandler 893
Santa Clara 674
Princeton 271
Medford 236
Singapore 225
Boardman 157
Roxbury 140
San Mateo 130
Wilmington 122
Ann Arbor 108
Beijing 108
Woodbridge 83
Bremen 77
Cambridge 72
New York 63
Nanjing 60
Munich 56
Des Moines 52
Ashburn 49
Düsseldorf 47
Mountain View 40
Jinan 35
Brussels 34
Caserta 29
Brno 27
Nanchang 27
Venice 26
Napoli 25
Shenyang 22
Los Angeles 21
Norwalk 21
Rome 21
Zhengzhou 20
Kunming 17
Guangzhou 16
Seoul 16
Shanghai 16
Helsinki 15
Tianjin 14
Changsha 13
Ningbo 12
Redwood City 11
Haikou 10
Hangzhou 10
Hebei 10
Hong Kong 10
Ottawa 10
Auburn Hills 9
Kraków 9
Milan 9
Naples 9
Lanzhou 8
Taizhou 8
Clifton 7
Houston 7
Groningen 6
Padova 6
West Jordan 6
Zanjan 6
Guadalajara 5
Jiaxing 5
Menlo Park 5
Andover 4
Aversa 4
Bagheria 4
Cesa 4
La Paz 4
London 4
Orange 4
Pittsburgh 4
Toronto 4
Atlanta 3
Bangkok 3
Catania 3
Changchun 3
Constanța 3
Erice 3
Fuzhou 3
Glis 3
Leawood 3
Lima 3
Namakkal 3
Palermo 3
Pinerolo 3
Sacramento 3
St Petersburg 3
Taipei 3
Taiyuan 3
Walnut 3
Washington 3
Wuxi 3
Auckland 2
Bakırköy 2
Bogotá 2
Bologna 2
Brembate 2
Brescia 2
Brisbane 2
Totale 7.547
Salva come PNG Salva come JPEG
Nome #
ANTI TNF ALFA IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE E SPONDILOARTRITI HBV CARRIERS OCCULTI:STUDIO RETROSPETTIVO SULLA SICUREZZA 206
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients 192
Detection of in vivo hepatitis B virus surface antigen mutations-A comparison of four routine screening assays 159
1) Analisi delle discontinuità di distribuzione e dei tempi di accumulo di radiocolloide in epatopatici cronici: risultati preliminari 144
ANTI-TNFα TREATMENT IS ASSOCIATED WITH INCREASED LIVER STIFFNESS IN HBV OCCULT CARRIER PATIENTS 93
Ittero in corso di infezione delle vie urinarie. Presentazione di un caso clinico ed aspetti patogenetici 84
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life 78
Effect of prednisone priming followed by alpha-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial 74
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 74
Patologie virali tropicali (Flavivirus, Filovirus, Arenavirus, Bunyavirus, Togavirus: Chikungunya, 72
Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance 69
Active recruitment strategy in disadvantaged immigrant populations improves the identification of human immunodeficiency but not of hepatitis B or C virus infections 68
Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues. 68
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 66
Prevention of the toxicity of erythromycin estolate in the perfused rat liver by endotoxin 65
3. HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years. 65
Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma. A Cancer of the Liver Italian Program (CLIP 08)retrospective case-control study 64
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients. 64
Recommendations for the management of acute hepatitis B: position paper of the italian Society for the study of infectious and tropical diseases 64
Endotoxin protects against chlorpromazine-induced cholestasis in the isolated perfused rat liver 64
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 64
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP) 63
Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: a controlled, randomized study 63
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 63
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 62
AISF position paper on liver disease and pregnancy 62
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis 61
Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial 61
Adefovir dipivoxil-associated thrombocytopenia in a patient with chronic hepatitis B 61
Influenza vaccination in patients with cirrhosis and in liver transplant recipients 60
A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy 59
Effects of bacterial lipopolysaccharide (LPS) on chlorpromazine (CPZ) induced cholestasis in the isolated perfused rat liver 59
Doctors in the kitchen. Experiments with cooking bivalve mollusks 58
Fever of unknown origin: a systematic review of the literature for 1995-2004 58
Effect of endotoxin tolerance on drug hepatotoxicity: amelioration of taurolithocholate cholestasis in the perfused rat liver 57
Liver's functional alterations produced from erythromycin estolate in the isolated and perfused rat liver 57
Bacterial endotoxin treatment ameliorates erythromycin estolate-induced cholestasis in the isolated perfused rat liver 57
Chronic endotoxin pretreatment protects from the chlorpromazine induced cholestasis 57
Discriminating value of serum bile acids in asymptomatic HBsAg carriers 57
Hepatitis C virus infection in Italy: a multicentric sero-epidemiological study. (A report from the HCV study group of the Italian Association for the study of the liver) 56
Liver toxicity during copper chronic intoxication in rats 56
Cholestasis induced by estradiol-17 beta-D-glucuronide: mechanisms and prevention by sodium taurocholate 56
[Elevata prevalenza ma bassa incidenza della infezione da HGV in pazienti con epatite cronica C] 56
[Spontaneous bacterial peritonitis in patients with liver cirrhosis. Differential aspects with portal thrombosis] 56
AISF position paper on HCV in immunocompromised patients 56
Rapid improvement of hepatic encephalopathy associated with oral ciprofloxacin treatment 55
Cholestatic effect of amphotericin B on the isolated perfused rat liver. Preliminary study 55
Absence of mutations in the YMDD motif/B region of the hepatitis B polymerase in famciclovir therapy failure 55
Endotoxin reduces erythromycine estolate-induced releas of aspartate transaminase from isolated rat liver cells 55
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta 55
AASLD Practice Guidelines on chronic hepatitis B and HBV infection in Italy 55
The role of surgery in transmitting "post-transfusion" hepatitis 55
Fattori di rischio per l'infezione tifoidea nell'area geografica del golfo di Napoli 55
Reduction of taurolithocholic acid-induced cholestasis in the isolated perfused rat liver by endotoxin treatment 55
Pretreatment of isolated rat hepatocytes with endotoxin decreases erythromicin estolate - induced aspartate transaminase release 55
Effect of bile acids on hepatic metabolism and biliary secretion of 16:0-(14C) 18:2 phosphatidylcholine 55
Bacterial endotoxin effect on liver plasma membranes (LPM): membrane-bound enzymes as probes of the site of interaction 55
Endotoxin treatment may modulate the expression of hepatotoxicity of membrane-active agents. 55
Amphotericin B-induced depression in the phagocytic function of the isolated rat liver and its prevention by nifedipine 54
Influence of tauroursodeoxycholic and taurodeoxycholic acids on hepatic metabolism and biliary secretion of phosphatidylcholine in the isolated rat liver 54
Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure 54
Epidemiology of hepatitis B virus (HBV) in Italy 54
Potentation of ethanol-induced narcosis in mice by pretreatment with bacterial lipopolysaccharide 54
Hepatitis delta infection in Italian patients: towards the end of the story? 54
Hepatic excretory function in the endotoxin tolerant rat 53
IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C 53
Effect of chronic copper administration on excretory function of rat liver 53
Clinical and histological aspects of chronic HCV infection and cirrhosis 52
The homeostasis model assessment of insulin resistance score is not predictive of sustained virologic response in chronic hepatiti s C patients 52
Effect of pretreatment with bacterial endotoxin on erythromycin estolate-induced cholestasis 52
Epidemiology of viral hepatitis in Italy 52
Effetto della eritromicina sulle funzioni escretorie del fegato di ratto isolato 52
Baseline HBV-DNA level is an important predictor of response to interferon in children with chronic hepatitis B 52
Virological patterns of HCV patients with failure to interferon-free regimens. 52
Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy 51
Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study 51
Efficacy of amphotericin B colloidal dispersion in the treatment of Mediterranean visceral leishmaniasis in immunocompetent adult patients 51
Hepatitis B in pregnancy. 51
Endotoxin treatment of isolated hepatocytes reduces chlorpromazine-induced aspartate transaminase release 51
Studio prospettico controllato del trattamento prednisone interferone in pazienti pediatrici con epatite cronica da HBV 51
Reactivation of hepatitis B virus in cancer patients treated with chemotherapy for solid tumors. Is the prophylaxis really required? 51
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 51
Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates) 50
Tamoxifen in the treatmnent of hepatocellular carcinoma: 5 years results of the CLIP-1 multicentre randomised controlled trial 50
Metabolic changes associated with endotoxin tolerance: effect on bile secretion 50
Different changes in mitochondrial apoptotic pathway in lymphocytes and granulocytes in cirrhotic patients with sepsis. 50
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 50
Successful treatment with ciprofloxacin of Salmonella typhimurium infection in an immunocompromised host 49
Evolving Clinical Landscape of Chronic Hepatitis B:A Multicenter Italian Study 49
Salvage therapy with tenofovir followed by adefovir maintenance in a cirrhotic patient with a lamivudine resistant HBV flare. 49
Etiological, clinical and laboratory data of post-transfusion hepatitis: a retrospective study of 379 cases from 53 Italian hospitals 49
Does an "autoimmune"profile affect the clinical profile of chronic hepatitis C? An italian multicentre survey 48
Clearance of viable salmonella typhi Ty 2 and Staphylococcus aureus by the isolated rat liver in the absence of serum factors 48
Taurocholate but not dehydrocholate can reverse the cholestatic effects of estradiol-17-B-glucuronide in the isolated perfused rat liver 48
Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop 47
Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study 47
HBsAg carriers among blood donors in Italy; a retrospective survey of data from 189 blood banks 47
Treatment of chronic Hepatitis C: a smart coat over a ragged dress? 47
Endotoxemia in a series of 104 patients with chronic liver diseases: prevalence and significance 47
Effects of endotoxins on hepatic excretory function 47
Totale 6.150
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.952
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.952
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020574 0 0 0 0 0 14 269 61 129 43 50 8
2020/20211.987 202 11 237 92 372 22 272 220 13 264 222 60
2021/20221.690 148 11 17 62 590 14 30 65 70 97 132 454
2022/20233.346 293 45 38 302 311 286 6 216 1.694 26 56 73
2023/20241.143 113 34 51 110 438 75 10 35 4 25 57 191
2024/20251.055 58 53 34 102 502 306 0 0 0 0 0 0
Totale 12.209